The 19q12 bladder cancer GWAS signal: Association with cyclin E function and aggressive disease

Cancer Research

Volumn 74, Issue 20, 2014, Pages 5808-5818

  Fu, Yi Ping ^a   Kohaar, Indu ^a   Moore, Lee E ^a   Lenz, Petra ^b   Figueroa, Jonine D ^a   Tang, Wei ^a   Porter Gill, Patricia ^a   Chatterjee, Nilanjan ^a   Scott Johnson, Alexandra ^a   Garcia Closas, Montserrat ^c   Muchmore, Brian ^a   Baris, Dalsu ^a   Paquin, Ashley ^a   Ylaya, Kris ^a   Schwenn, Molly ^d   Apolo, Andrea B ^a   Karagas, Margaret R ^e   Tarway, McAnthony ^a   Johnson, Alison ^f   Mumy, Adam ^a   Schned, Alan ^e   Guedez, Liliana ^a   Jones, Michael A ^g   Kida, Masatoshi ^h   Hosain, G M Monawar ⁱ   Malats, Nuria ^j   Kogevinas, Manolis ^k,l,m,n   Tardon, Adonina ^n,o   Serra, Consol ^n,p   Carrato, Alfredo ^q   Garcia Closas, Reina ^r   Lloreta, Josep ^p   Wu, Xifeng ^s   Purdue, Mark ^a   Andriole, Gerald L ^t   Grubb, Robert L ^t   Black, Amanda ^a   Landi, Maria T ^a   Caporaso, Neil E ^a   Vineis, Paolo ^u,v   Siddiq, Afshan ^u   Bueno de Mesquita, H Bas ^u,w,x,y   Trichopoulos, Dimitrios ^z,aa,ab   Ljungberg, Börje ^ac   Severi, Gianluca ^v,ad,ae   Weiderpass, Elisabete ^af,ag,ah,ai   Krogh, Vittorio ^aj   Dorronsoro, Miren ⁿ   Travis, Ruth C ^ak   Tjønneland, Anne ^al   Brennan, Paul ^am   Chang Claude, Jenny ^an   Riboli, Elio ^u   Prescott, Jennifer ^z,ao   Chen, Constance ^z   De Vivo, Immaculata ^z,ao   Govannucci, Edward ^z   Hunter, David ^z   Kraft, Peter ^z   Lindstrom, Sara ^z   Gapstur, Susan M ^ap   Jacobs, Eric J ^ap   Diver, W Ryan ^ap   Albanes, Demetrius ^a   Weinstein, Stephanie J ^a   Virtamo, Jarmo ^aq   Kooperberg, Charles ^ar   Hohensee, Chancellor ^ar   Rodabough, Rebecca J ^ar   Cortessis, Victoria K ^as   Conti, David V ^as   Gago Dominguez, Manuela ^at   Stern, Mariana C ^as   Pike, Malcolm C ^au   Van Den Berg, David ^as   Yuan, Jian Min ^av   Haiman, Christopher A ^as   Cussenot, Olivier ^aw,ax,ay   Cancel Tassin, Geraldine ^ax,ay   Roupret, Morgan ^ax,ay,az   Comperat, Eva ^ax,ay,az   Porru, Stefano ^ba   Carta, Angela ^ba   Pavanello, Sofia ^bb   Arici, Cecilia ^ba   Mastrangelo, Giuseppe ^bb   Grossman, H Barton ^s   Wang, Zhaoming ^b   Deng, Xiang ^b   Chung, Charles C ^b   Hutchinson, Amy ^b   Burdette, Laurie ^b   Wheeler, William ^bc   Fraumeni, Joseph ^a   Chanock, Stephen J ^a   Hewitt, Stephen M ^a   Silverman, Debra T ^a   Rothman, Nathaniel ^a   Prokunina Olsson, Ludmila ^a   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^d Maine Cancer Registry   (United States)

^e DARTMOUTH MEDICAL SCHOOL   (United States)

^f Vermont Cancer Registry   (United States)

^g MAINE MEDICAL CENTER   (United States)

^h UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

ⁱ New Hampshire Cancer Registry   (United States)

^j Structural Biology and Biocomputing Programme   (Spain)

^k CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^l HOSPITAL DEL MAR   (Spain)

^m NATIONAL SCHOOL OF PUBLIC HEALTH   (Greece)

ⁿ CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^o UNIVERSITY OF OVIEDO   (Spain)

^p UNIVERSITAT POMPEU FABRA   (Spain)

^q HOSPITAL RAMÓN Y CAJAL   (Spain)

^r HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^s UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^t WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^u IMPERIAL COLLEGE LONDON   (United Kingdom)

^v HuGeF Human Genetics Foundation Torino   (Italy)

^w NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^x UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^y UNIVERSITY OF MALAYA   (Malaysia)

^z HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^aa BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^ab HELLENIC HEALTH FOUNDATION   (Greece)

^ac UMEÅ UNIVERSITY   (Sweden)

^ad CANCER EPIDEMIOLOGY CENTRE   (Australia)

^ae UNIVERSITY OF MELBOURNE   (Australia)

^af UNIVERSITY OF TROMSØ   (Norway)

^ag CANCER REGISTRY OF NORWAY   (Norway)

^ah KAROLINSKA INSTITUTE   (Sweden)

^ai FOLKHÄLSAN RESEARCH CENTER   (Finland)

^aj NATIONAL CANCER INSTITUTE   (Italy)

^ak UNIVERSITY OF OXFORD   (United Kingdom)

^al DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^am INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^an GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^ao HARVARD MEDICAL SCHOOL   (United States)

^ap AMERICAN CANCER SOCIETY   (United States)

^aq NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^ar USA   (United States)

^as UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^at HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^au MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^av UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^aw HÔPITAL TENON   (France)

^ax CeRePP Group   (France)

^ay SORBONNE UNIVERSITÉ   (France)

^az PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^ba UNIVERSITY OF BRESCIA   (Italy)

^bb UNIVERSITY OF PADOVA   (Italy)

^bc INFORMATION MANAGEMENT SERVICES INC   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN E1; MESSENGER RNA; TUMOR MARKER; UNCLASSIFIED DRUG; CCNE1 PROTEIN, HUMAN; CYCLIN E; ONCOPROTEIN;

ARTICLE; BLADDER CANCER; CCNE1 GENE; CHROMOSOME 19Q; CONTROLLED STUDY; FEMALE; GENE LOCATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC MARKER; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MARKER GENE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR INVASION; UPREGULATION; BLADDER; BLADDER TUMOR; CASE CONTROL STUDY; CHROMOSOME 19; GENE EXPRESSION; GENE FREQUENCY; GENETICS; HAPLOTYPE; HELA CELL LINE; METABOLISM; PATHOLOGY;

CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 19; CYCLIN E; GENE EXPRESSION; GENE FREQUENCY; GENOME-WIDE ASSOCIATION STUDY; HAPLOTYPES; HELA CELLS; HUMANS; ONCOGENE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 84908426306     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-14-1531     Document Type: Article

References (31)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013;63:11-30.
2. Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001;19:666-75.
3. Guey LT, Garcia-Closas M, Murta-Nascimento C, Lloreta J, Palencia L, Kogevinas M, et al. Genetic susceptibility to distinct bladder cancer subphenotypes. Eur Urol 2010;57:283-92.
4. Hernandez S, Lopez-Knowles E, Lloreta J, Kogevinas M, Amoros A, Tardon A, et al. Prospective study of FGFR3 mutations as a prognostic factor in nonmuscle invasive urothelial bladder carcinomas. J Clin Oncol 2006;24:3664-71.
5. Rothman N, Garcia-Closas M, Chatterjee N, Malats N, Wu X, Figueroa JD, et al. A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet 2010;42:978-84.
6. Figueroa JD, Ye Y, Siddiq A, Garcia-Closas M, Chatterjee N, Prokunina-Olsson L, et al. Genome-wide association study identifies multiple loci associated with bladder cancer risk. Hum Mol Genet 2014;23:1387-98.
7. Wu X, Ye Y, Kiemeney LA, Sulem P, Rafnar T, Matullo G, et al. Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer. Nat Genet 2009;41:991-5.
8. Kiemeney LA, Thorlacius S, Sulem P, Geller F, Aben KK, Stacey SN, et al. Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat Genet 2008;40:1307-12.
9. Lew DJ, Dulic V, Reed SI. Isolation of three novel human cyclins by rescue of G1 cyclin (Cln) function in yeast. Cell 1991;66:1197-206.
10. Donnellan R, Chetty R. Cyclin E in human cancers. FASEB J 1999;13:773-80.
11. Glotzer M, Murray AW, Kirschner MW. Cyclin is degraded by the ubiquitin pathway. Nature 1991;349:132-8.
12. Nakayama N, Nakayama K, Shamima Y, Ishikawa M, Katagiri A, Iida K, et al. Gene amplification CCNE1 is related to poor survival and potential therapeutic target in ovarian cancer. Cancer 2010;116:2621-34.
13. Liu Y, Cai H, Liu J, Fan H, Wang Z, Wang Q, et al. A miR-151 binding site polymorphism in the 3′-untranslated region of the cyclin E1 gene associated with nasopharyngeal carcinoma. Biochem Biophys Res Commun 2013;432:660-5.
14. Forbes SA, Bindal N, Bamford S, Cole C, Kok CY, Beare D, et al. COSMIC: mining complete cancer genomes in the catalogue of somatic mutations in cancer. Nucleic Acids Res 2011;39:D945-50.
15. Fu YP, Kohaar I, Rothman N, Earl J, Figueroa JD, Ye Y, et al. Common genetic variants in the PSCA gene influence gene expression and bladder cancer risk. Proc Natl Acad Sci U S A 2012;109:4974-9.
16. Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE, et al. An integrated map of genetic variation from 1,092 human genomes. Nature 2012;491:56-65.
17. Howie BN, Donnelly P, Marchini J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet 2009;5:e1000529.
18. Kohaar I, Porter-Gill P, Lenz P, Fu YP, Mumy A, Tang W, et al. Genetic variant as a selection marker for anti-prostate stem cell antigen immunotherapy of bladder cancer. J Natl Cancer Inst 2013;105:69-73.
19. Lenz P, Pfeiffer R, Baris D, Schned AR, Takikita M, Poscablo MC, et al. Cell-cycle control in urothelial carcinoma: large-scale tissue array analysis of tumor tissue from Maine and Vermont. Cancer Epidemiol Biomarkers Prev 2012;21:1555-64.
20. Bernstein BE, Birney E, Dunham I, Green ED, Gunter C, Snyder M. An integrated encyclopedia of DNA elements in the human genome. Nature 2012;489:57-74.
21. Goode EL, Fridley BL, Vierkant RA, Cunningham JM, Phelan CM, Anderson S, et al. Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk. Cancer Epidemiol Biomarkers Prev 2009;18:935-44.
22. Han JY, Wang H, Xie YT, Li Y, Zheng LY, Ruan Y, et al. Association of germline variation in CCNE1 and CDK2 with breast cancer risk, progression and survival among Chinese Han women. PLoS One 2012;7:e49296.
23. Sewing A, Ronicke V, Burger C, Funk M, Muller R. Alternative splicing of human cyclin E. J Cell Sci 1994;107:581-8.
24. Mumberg D, Wick M, Burger C, Haas K, Funk M, Muller R. Cyclin ET, a new splice variant of human cyclin E with a unique expression pattern during cell cycle progression and differentiation. Nucleic Acids Res 1997;25:2098-105.
25. Matsumoto Y, Maller JL. A centrosomal localization signal in cyclin E required for Cdk2-independent S phase entry. Science 2004;306:885-8.
26. Moore JD. In the wrong place at the wrong time: does cyclin mislocalization drive oncogenic transformation? Nat Rev Cancer 2013;13:201-8.
27. Moore JD, Yang J, Truant R, Kornbluth S. Nuclear import of Cdk/cyclin complexes: identification of distinct mechanisms for import of Cdk2/cyclin E and Cdc2/cyclin B1. J Cell Biol 1999;144:213-24.
28. Soderberg O, Gullberg M, Jarvius M, Ridderstrale K, Leuchowius KJ, Jarvius J, et al. Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat Methods 2006;3:995-1000.
29. Ekholm-Reed S, Mendez J, Tedesco D, Zetterberg A, Stillman B, Reed SI. Deregulation of cyclin E in human cells interfereswith prereplication complex assembly. J Cell Biol 2004;165:789-800.
30. Kawamura K, Izumi H, Ma Z, Ikeda R, Moriyama M, Tanaka T, et al. Induction of centrosome amplification and chromosome instability in human bladder cancer cells by p53 mutation and cyclin E overexpression. Cancer Res 2004;64:4800-9.
31. Geisen C, Moroy T. The oncogenic activity of cyclin E is not confined to Cdk2 activation alone but relies on several other, distinct functions of the protein. J Biol Chem 2002;277:39909-18.